O'Dell Group’s Agilon Health AGL Stock Holding History

O'Dell Group’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40	Closed	-$25K	–	454
2022 Q1	$25K	Hold	40	–	–	0.01%	237
2021 Q4	$27K	Buy	+40	New	+$24.3K	0.01%	213

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

O'Dell Group's AGL Position: Q2 2022 in Review

O'Dell Group sold out of Agilon Health (AGL) in Q2 2022, closing a stake of 40 shares — an estimated $25K sold.

O'Dell Group first reported a position in AGL in Q4 2021 and held it in 2 quarters. The position peaked at $27K in Q4 2021. 148 funds tracked by Wall St. Rank hold AGL as of Q2 2022.

O'Dell Group reported no remaining Agilon Health position as of Q2 2022 after selling out during the quarter.
O'Dell Group sold 40 Agilon Health shares in Q2 2022, an estimated $25K.
O'Dell Group first reported a position in Agilon Health in Q4 2021 and held it in 2 quarters.
O'Dell Group's Agilon Health position peaked at $27K in Q4 2021.
148 funds tracked by Wall St. Rank held Agilon Health as of Q2 2022.

Based on O'Dell Group's 13F filing for Q2 2022, filed 11 Aug 2022.